Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
19 August, 2017 14:54 IST
Dr Reddy's climbs after USFDA clearance for plant
Source: IRIS | 14 Jun, 2017, 10.31AM
Comments  |  Post Comment

Dr Reddy's Laboratories witnessed a rise in share price on Wednesday after the company said that it has received Establishment Inspection Report (EIR) from the United States Food and Drug Administration on June 13, 2017 after closure of audit for the company's API manufacturing plant at Miryalaguda.

This unit was inspected by the USFDA in February 2017 and DRL was issued form 483 with three observations. 

Shares of Dr Reddy'S Laboratories are trading at Rs 2,696.95, up Rs 68.85, or 2.62% at the Bombay Stock Exchange (BSE) on Wednesday at 10:19 a.m.

The scrip has touched an intra-day high of Rs 2,698 and low of Rs 2,647. The total volume of shares traded at the BSE is 28,601.

Total volume of shares traded on the bourses today was lower by 42.60% to 288,777 compared with 22-day average volume of 503,120.

Dr Reddy`S Laboratories Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Security Code type    into this box
Related Articles
Tata Global Beverage surges after water brand forays into US - 16-Aug-2017 10:36
Tech Mahindra jumps after good Q1 results - 01-Aug-2017 10:03
VA Tech Wabag climbs on bagging STP order worth Rs 3.86 bn - 27-Jul-2017 10:16
Reliance climbs after good Q1 consolidated net profit - 21-Jul-2017 11:03
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer